Ionis Pharmaceuticals Inc
(MEX:IONS)
MXN
1,150
(0%)
Market Cap: 168.65 Bil
Enterprise Value: 170.78 Bil
PE Ratio: 0
PB Ratio: 19.67
GF Score: 72/100 Ionis Pharmaceuticals Inc at Stifel CNS Days (Virtual) Transcript
Mar 28, 2022 / 03:00PM GMT
Release Date Price:
MXN631.58
Paul Andrew Matteis
Stifel, Nicolaus & Company, Incorporated, Research Division - Co-Head of the Biotech Team, MD & Senior Analyst
Great. Thanks very much, everybody, for continuing on. It's my pleasure to be hosting Eric Swayze, Executive Vice President of Research at Ionis; and Holly Kordasiewicz, who runs their neurology research group. We have a lot of stuff to get into, a lot of programs. We can talk maybe a little bit about today's data release as well and any implications.
Questions & Answers
Paul Andrew Matteis
Stifel, Nicolaus & Company, Incorporated, Research Division - Co-Head of the Biotech Team, MD & Senior Analyst
But do you want to maybe just kick it off, either Eric or Holly, and just talk a bit about your neuro pipeline right now and where the different programs stand?
Eric E. Swayze
Ionis Pharmaceuticals, Inc. - EVP of Research
Yes. I'd love to do that, and thanks for having us on, Paul. I think that a little overview of our neuro portfolio strategy and depth is
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot